Napier Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Napier Financial's BMY Position: Q2 2026 in Review
Napier Financial reduced its Bristol-Myers Squibb (BMY) stake by 4.6% in Q2 2026, selling an estimated $287 and leaving 103 shares worth $5.93K. The position accounts for ﹤0.01% of the portfolio, ranked #367.
Napier Financial first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $6.55K in Q1 2026. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Napier Financial held 103 shares of Bristol-Myers Squibb worth $5.93K as of Q2 2026.
- Napier Financial sold 5 Bristol-Myers Squibb shares in Q2 2026, an estimated $287.
- Bristol-Myers Squibb made up ﹤0.01% of Napier Financial's portfolio in Q2 2026, its #367 holding.
- Napier Financial first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- Napier Financial's Bristol-Myers Squibb position peaked at $6.55K in Q1 2026.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Napier Financial's 13F filing for Q2 2026, filed 31 Jul 2026.